Cardior

Cardior Pharmaceuticals

This biopharmaceutical company develops RNA-based therapeutics to prevent and repair heart disease for patients with conditions such as heart failure and myocardial infarction.

Cardurion Pharmaceuticals

This clinical-stage biotechnology company develops therapeutic drugs for patients with heart failure and other cardiovascular diseases.

Phlox Therapeutics

This company develops RNA-based gene therapies to treat patients with rare genetic heart diseases, including cardiomyopathies and laminopathies.

Kardigan

This company develops precision cardiovascular medicines and a clinical intelligence platform for patients with heart diseases such as dilated cardiomyopathy and hypertension.

Brano Therapeutics

This company develops small-molecule inhibitors to treat heart failure and metabolic dysfunction for patients with cardiovascular diseases.

Cardiatec

This company develops an artificial intelligence platform to identify novel drug targets and therapeutics for cardiovascular diseases for the pharmaceutical and healthcare industries.

Revier Therapeutics

This company develops orally available small molecules targeting class IIa histone deacetylases to treat patients with heart failure and atherosclerotic cardiovascular diseases.

AnaCardio

This biopharmaceutical company develops oral small-molecule drugs to improve cardiac contractility in patients with heart failure.